Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Xperi Inc. Completes its Spin-Off to Become an Independent Public Company
2022-10-10 09:00
Legendary Cocktail Bar Maison Ikkoku Set to Close
2022-10-10 09:00
Solving Advanced Algebraic Equations as Young as 7 years old
2022-10-10 08:38
On World Mental Health Day, NCCN Announces Free Updated Distress Screening Tool, Available in More Than 70 Languages
2022-10-10 08:34
330 Students Thrived and were Recognised for Achieving Five Years Beyond Their School Grade Levels Despite Pandemic Challenges
2022-10-10 08:24
The China NMPA Approves Selpercatinib for the Treatment of Patients with RET-driven Lung and Thyroid Cancers
2022-10-10 08:23
The China NMPA Approved CYRAMZA® (ramucirumab) for the Treatment in Patients with Hepatocellular Carcinoma
2022-10-10 08:20
Ascletis Announces Dosing of 24 Healthy Subjects of the First 3 Cohorts in Multiple-Dose Escalation Phase I Clinical Trial of Oral RdRp Inhibitor ASC10 for COVID-19
2022-10-10 08:10
Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW014, an oral small molecule GLP-1 receptor agonist for the Treatment of Obesity and Type 2 Diabetes
2022-10-10 08:00
WuXi Biologics Co., Ltd. Removed from Unverified List
2022-10-10 07:55
Raise Finance ramps up leads, marketing and growth with new combination of Salestrekker and WebloanQ
2022-10-10 06:00
HK's integration with GBA opens new chapter
2022-10-09 20:58
Digitalization leads to better life of Chinese people
2022-10-09 19:26
AXA BetterMe Weekend concludes on a high note
2022-10-09 18:57
Goldwind and Masdar, Abu Dhabi Future Energy Strike Deal Bringing the Largest Wind Project in Central Asia
2022-10-09 18:50
Unbeatable Superior 4K Display-Toshiba TV M550K
2022-10-09 12:40
China and its Southeast Asian neighbors need to enhance industrial cooperation
2022-10-09 09:18
17Sing APP 8.0 update Improves UX and brings new features for social interaction
2022-10-09 09:00
Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma, new study presented at UEG Week suggests
2022-10-09 06:01
Bairong Inc. Hosts the 2022 Digital Intelligence Conference; Announces Ambitious Plans to Become Industry Leader
2022-10-08 20:00
1
1468
1469
1470
1471
1472
5281